How likely is it for a person to develop arthritis from rubella vaccine?
Arthralgia (joint pain) and transient arthritis (joint redness or swelling) following rubella vaccination occur only in persons who were susceptible to rubella at the time of vaccination. Joint symptoms are uncommon in children and in adult males. About 25% of post-pubertal women report joint pain after receiving rubella vaccine, and about 10% report arthritis-like signs and symptoms. When joint symptoms occur, they generally begin 1-3 weeks after vaccination, persist for 1 day to 3 weeks, and rarely recur. Chronic joint symptoms attributable to rubella vaccine are very rare, if they occur at all.
Arthralgia (joint pain) and transient arthritis (joint redness or swelling) following rubella vaccination occurs only in persons who were susceptible to rubella at the time of vaccination. Joint symptoms are uncommon in children and in adult males. About 25% of post-pubertal women report joint pain after receiving rubella vaccine, and about 10% report arthritis-like signs and symptoms. When joint symptoms occur, they generally begin 1–3 weeks after vaccination, persist for 1 day to 3 weeks, and rarely recur. Chronic joint symptoms attributable to rubella vaccine are very rare, if they occur at all.
Arthralgia (joint pain) and transient arthritis (joint redness or swelling) following rubella vaccination occurs only in persons who were susceptible to rubella at the time of vaccination. Joint symptoms are uncommon in children and in adult males. About 25% of post-pubertal women report joint pain after receiving rubella vaccine, and about 10% report arthritis-like signs and symptoms. When joint symptoms occur, they generally begin 13 weeks after vaccination, persist for 1 day to 3 weeks, and rarely recur. Chronic joint symptoms attributable to rubella vaccine are very rare, if they occur at all.
